Abera Bioscience AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Oct '25 Oct 16, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
Market Capitalization	114	69	75	62	173	-	Upgrade
Market Cap Growth	98.68%	-7.22%	20.46%	-64.21%	-	-	Upgrade
Enterprise Value	106	66	73	49	159	-	Upgrade
Last Close Price	6.20	4.51	5.16	4.80	16.55	-	Upgrade
PS Ratio	7.27	4.73	29.57	34.66	146.97	-	Upgrade
PB Ratio	14.72	8.00	13.20	3.69	5.94	-	Upgrade
P/TBV Ratio	14.72	8.00	13.20	3.69	5.94	-	Upgrade
EV/Sales Ratio	6.77	4.52	28.83	27.67	135.29	-	Upgrade
Asset Turnover	1.26	1.27	0.18	0.07	0.07	0.19	Upgrade
Quick Ratio	1.43	1.36	1.11	5.80	5.51	0.43	Upgrade
Current Ratio	1.79	2.15	2.02	6.33	5.60	0.43	Upgrade
Return on Equity (ROE)	-10.83%	-15.37%	-149.06%	-84.39%	-61.97%	-161.90%	Upgrade
Return on Assets (ROA)	-5.79%	-7.29%	-73.14%	-47.73%	-33.40%	-58.94%	Upgrade
Return on Capital (ROIC)	-8.74%	-11.70%	-94.29%	-52.95%	-38.77%	-102.87%	Upgrade
Earnings Yield	-0.78%	-1.59%	-22.40%	-31.28%	-5.29%	-	Upgrade
FCF Yield	4.71%	-1.92%	-23.73%	-31.78%	-5.59%	-	Upgrade
Buyback Yield / Dilution	-212.65%	-18.42%	-13.66%	-14.64%	-45.39%	-200.47%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.